# Dexmedetomidine Versus Ketamine as Adjuvants in Bariatric Surgery

> **NCT06738043** · NA · NOT_YET_RECRUITING · sponsor: **Tanta University** · enrollment: 90 (estimated)

## Conditions studied

- Obesity
- Postoperative Pain
- Bariatric Surgery

## Interventions

- **DRUG:** Dexmedetomidine infusion
- **DRUG:** Ketamine infusion
- **DRUG:** Normal Saline Infusion (Placebo)

## Key facts

- **NCT ID:** NCT06738043
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-20
- **Primary completion:** 2027-04-20
- **Final completion:** 2027-04-20
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06738043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06738043, "Dexmedetomidine Versus Ketamine as Adjuvants in Bariatric Surgery". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06738043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*